The loss of Bristol-Myers Squibb under GAAP for 6 months of 2020 amounted to $ 0.846 billion, compared to a profit of $3.154 billion in the previous year. Revenue increased by 71.5% to $20.91 billion, compared to $12.193 billion a year earlier.
The loss of Bristol-Myers Squibb under GAAP for 6 months of 2020 amounted to $ 0.846 billion, compared to a profit of $3.154 billion in the previous year. Revenue increased by 71.5% to $20.91 billion, compared to $12.193 billion a year earlier. 
news.bms.com
English (US) 